CNBC Africa Open Exchange: 9 March 2017
CNBC’s Bronwyn Nielsen unpacks the interim results with Stephen Saad
BusinessDay TV - The week that was - 10 June 2016 -
Join Simon Brown, Giulietta Talevi and Sasfin Securities'
David Shapiro as they discuss Aspen’s R7 billion deal with
Aspen, AstraZeneca ink R7BN deal
Aspen CEO Stephen Saad speaks to Alishia Seckam
and Stephen Gunnion about the group’s R7 billion deal
with AstraZeneca that will add seven established medicines
in 100 countries to the group’s portfolio;
CNBC Captains of Industry 15 March 2016
Stephen Saad speaks to CNBC Africa’s Executive Director
Bronwyn Nielsen on the challenges of doing business in
the pharmaceutical industry, succession planning,
diversification and expansion
BusinessDay TV - Aspen posts 14% rise in H1 profit-
Stephen Saad, CEO of Aspen, speaks to Alishia Seckam
about first-half results, which show a 14% rise in normalised
Aspen CEO On Currency Pressures:
Aspen Pharmacare, Africa's largest generic-drug maker,
posted a 3.9 percent gain in full-year profit, as the
expansion of its international business outweighed the rising
cost of imported materials. CNBC Africa's David Williams
spoke with CEO, Steven Saad for more.
Giulietta Talevi and Alishia Sekam discussed the results
and currency volatility with Stephen Saad
Siki Mgabadeli chatted to Stephen Saad about the year
end results and the Group's rapid international growth.
Fine Business Radio:
Lindsay Williams analyzed the results with Stephen Saad
and discussed the Group’s continued global success
14 September 2015: BusinessDay TV Stock Pick -
Liston Meintjes from Sasfin Asset Management takes
Giulietta Talevi through his stock pick of the day:
ASPEN / R311.00 / Up 1.09%
Aspen interim results interviews for the six months ended 31 December 2014
Aspen’s half year gross revenue surged by 47% to
CNBC Africa’s David Williams chatted with Aspen Group
Chief Executive Stephen Saad about the results.
CNBC Africa: Aspen - Hot or Not -
Guest Rowan Willams from Nitrogen Fund Managers and
Byron Lotter from Vestact has selected Aspen as today's stock
pick within the pharmaceuticals sector.
CNBC Africa - Talking Stocks: 18 February 2016
CNBC Africa's Gugulethu Cele
talks to Sean Ashton and Liam Hechter from Anchor
Capital talk about Aspen with Liam and Sean both rating
Aspen as a Buy
Fine Business Radio’s
Lindsay Williams spoke to Stephen Saad about Aspen’s
remarkable growth and results.
Hanna Barry and Gus Attridge focused on Aspen’s results,
consolidation prospects and its strategy across emerging
21 December 2015.
CNN Marketplace addressing some of Africa’s health
challenges with Stavros Nicolaou.
11 September 2015: BusinessDay TV -
The week that was - Stephen Gunnion, Giulietta Talevi and
Sasfin's David Shapiro round up the week's biggest
business news. View the footage about Aspen from
16 July 2015: CNBC Africa -
Aspen’s prospects in Russia Senior executive at Aspen
Pharmacare, Stavros Nicolaou, who is also a member of
South Africa's BRICS business council --spoke to CNBC
Africa during the recent BRICS summit about the prospects
that exist for the pharmaceutical heavyweight to
enter the Russian market.
13 March 2015: CNBC Africa -
GSK sells half of its stake in Aspen British drug
manufacturer GlaxoSmithKline has sold half of its
shareholding in Aspen Pharmacare for ZAR10.5.
Joining CNBC Africa to discuss more about the selloff
as well as GSK's relationship with Aspen is the latter's
deputy group chief executive Gus Attridge.
Aspen year end results interviews for the period ended 30 June 2014
Bloomberg TV Africa:
Bronwyn Seaborne spoke to CEO Stephen Saad about
Aspen’s expansion of it’s African Footprin
Aspen interim results interviews for the six months ended 31 December 2013
Aspen financial results for the year ended 30 June 2013
Aspen announces a US$ 1 billion deal with MSD
CNBC Africa Closing Bell Samantha Loring and
Stephen Saad Business Day TV- Stephen Gunnion and
Aspen year end results interviews for the
six months ended 31 December 2012
CNBC Africa - Business Tonight. Erika van der Merwe
and Ivy Asset Management’s Bruce Main review the results